American Thoracic Society 2024 Respiratory Innovation Summit
SMSbiotech has been selected for an oral showcase at the prestigious American Thoracic Society (ATS) 2024 Respiratory Innovation Summit (RIS)!
The American Thoracic Society hosts the Respiratory Innovation Summit, which unites the innovators, investors, clinicians, and advocacy groups who lead the charge to create powerful new treatments for deadly and crippling diseases of the lungs and airways.
This meeting historically attracts 350+ global leaders representing all facets of the respiratory industry, including representatives from start-ups, business development, venture capital, government, academia, and clinical medicine.
This is a huge honor! Out of many applications, we were chosen as one of only 25 companies to present our work.
A testament to the importance of groundbreaking platform technology and an incredible opportunity to:
- Share our groundbreaking research and development progress with a distinguished audience of industry leaders, medical professionals, and patient advocates.
- Spark essential conversations that can lead to advancements in respiratory regenerative healthcare.
- Gain valuable exposure to potential partners and collaborators in this field of medicine.
Stay tuned for more details about the showcase!
You can visit the ATS website: https://conference.thoracic.org/program/ris/ to learn more about the summit.
